<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04686695</url>
  </required_header>
  <id_info>
    <org_study_id>taVNS-MD-2020</org_study_id>
    <nct_id>NCT04686695</nct_id>
  </id_info>
  <brief_title>Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease</brief_title>
  <official_title>Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Meniere Disease: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tongren Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tongren Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To evaluate the effect of Transcutaneous auricular vagus nerve stimulation for the&#xD;
      patients Meniere disease.&#xD;
&#xD;
      Methods: We accrued 25 patients at Beijing TongRen Hospital. All treatments were&#xD;
      self-administered by the patients at home after training at the hospital. Patients completed&#xD;
      questionnaires at baseline and after 4 weeks, 8 weeks, 12 weeks.&#xD;
&#xD;
      Tinnitus Handicap Inventory (THI), Dizziness Handicap Inventory (DHI), Pure Tone Audiometry,&#xD;
      visual scale of ear stuffiness and SF-36 were performed to evaluate the therapeutic effects.&#xD;
&#xD;
      A difference of P &lt; 0.05 was considered statistically significant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">May 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean change from Baseline in the Tinnitus Handicap Inventory (THI) rating scale at 12 Weeks</measure>
    <time_frame>Day 0 and postintervention at Week 12</time_frame>
    <description>Tinnitus Handicap Inventory (THI) to measure the subjective tinnitus symptoms. Tinnitus Handicap Inventory (THI) to measure the subjective tinnitus symptoms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean change from Baseline in the Dizziness Handicap Inventory (DHI) at 12 Weeks</measure>
    <time_frame>Day 0 and postintervention at Week 12</time_frame>
    <description>DHI to measure the subjective dizziness symptoms.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mean change from Baseline in the Pure Tone Audiometry at 12 Weeks</measure>
    <time_frame>Day 0 and postintervention at Week 12</time_frame>
    <description>Pure Tone Audiometry to measure the audition.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean change from Baseline in the 36-items Short Form(SF-36) at 12 Weeks</measure>
    <time_frame>Day 0 and postintervention at Week 12</time_frame>
    <description>SF-36 to measure quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean change from Baseline in the visual scale of ear stuffiness at 12 Weeks</measure>
    <time_frame>Day 0 and postintervention at Week 12</time_frame>
    <description>Visual scale to measure the subjective ear stuffiness symptoms</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Meniere Disease</condition>
  <arm_group>
    <arm_group_label>Transcutaneous Auricular Vagus Nerve Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>taVNS</intervention_name>
    <description>taVNS was applied using a Huatuo stimulator (SDZ-IIB) developed by Suzhou manufacture of Medical Device and Material. Stimulation parameters was 1 mA of electrical current at a frequency of 20 Hz with pulse duration â‰¤ 1 ms, for 30min,administered twice daily.</description>
    <arm_group_label>Transcutaneous Auricular Vagus Nerve Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age &gt;=18 and Age &lt;=70.&#xD;
&#xD;
          2. Clinical diagnosis of meniere disease.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. History of depression, tumors, thyroid disease, diabetes, cardiac diseases.&#xD;
&#xD;
          2. History of Otorhinolaryngology surgery.&#xD;
&#xD;
          3. Pregnant or lactating women.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>66 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beijing Tongren Hospital</name>
      <address>
        <city>Beijing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 23, 2020</study_first_submitted>
  <study_first_submitted_qc>December 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>December 23, 2020</last_update_submitted>
  <last_update_submitted_qc>December 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transcutaneous auricular vagus nerve stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meniere Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

